Detection of SARS-CoV-2 at the point of care

Loeffelholz MJ, Tang Y | Bioanalysis doi: 10.4155/bio-2021-0078 (2021) (Epub ahead of print) Keywords: COVID-19 • home testing • nucleic acid amplification testing • POCT • pooled specimen screening • rapid antigen testing • SARS-CoV-2 Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the etiologic agent of COVID-19. Testing for SARS-CoV-2 infection is a critical element of the public health response to COVID-19. Point-of-care (POC) tests can drive patient management decisions for infectious diseases, including COVID-19. POC tests are available for the diagnosis of SARS-CoV-2 infections and include those that detect SARS-CoV-2 antigens as well as amplified RNA sequences. We provide a review...

To view this content, please register now for access

It's completely free